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ABSTRACT. We describe a case of retinoblastoma with an atypical 
presentation and previously unreported cytogenetic aberrations. A 
19-month-old girl with left intraocular retinoblastoma was treated 
with enucleation and chemotherapy. The disease showed aggressive 
evolution within a short period between diagnosis and relapse. Eight 
months after diagnosis, a new large tumor was present in the orbit of the 
right eye, with diffuse bone pain, pancytopenia and diffuse infiltration 
into the bone marrow and the central nervous system. The child did 
not respond to treatment and died. Cytogenetic studies made with 
G-banding, FISH and SKY analysis showed chromosomal aberrations 
commonly associated with retinoblastoma, including del(13q), i(6p), 
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+1, and monosomy 16, along with others that had not been reported 
previously, including dup(5q), dic(15;22) and add(14q). The new 
chromosomal aberrations may be related to the aggressiveness of the 
disease in this case.
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INTRODUCTION
Retinoblastoma (Rb) is the most common intraocular malignancy in childhood, with 
an annual incidence of 1/15,000-20,000 live births (Aerts et al., 2006). It can be unifocal or 
multifocal, affecting one or both eyes at the same time, and it is termed sporadic or hereditary. 
It requires complex treatment, encompassing several therapeutic strategies in order to preserve 
life and eyesight (Erwenne et al., 2003).
Rb can infiltrate the brain via the optic nerve or the adjacent tissues, and thus, the 
disease can become extraocular (Chintagumpala et al., 2007). Metastatic disease with no evi-
dence of optic nerve involvement is rare. Lumbar puncture with cerebrospinal fluid analysis 
and bone marrow aspiration are not routinely performed. However, these tests are indicated 
in children with advanced intraocular disease or with evidence of extraocular disease at pre-
sentation (Melamud et al., 2006). Rb can disseminate to other parts of the body including the 
bone marrow, although this rarely occurs, and it is generally scattered among normal elements 
(Khurshid et al., 2004). Some tumors such as neuroblastoma and medulloblastoma can fully 
infiltrate the bone marrow and thus simulate acute leukemia (Inoue et al., 1974). Neverthe-
less, when this pattern of disease occurs, it provides us the opportunity to examine directly the 
karyotype of the tumor cells. The specific cytogenetic abnormalities may also be of value in 
suggesting the diagnosis of the disease (Daly et al., 1987; Oliveros and Yunis, 1995).
The present study describes an atypical case of a child with left intraocular Rb at di-
agnosis who was treated with enucleation prior to chemotherapy. However, eight months after 
diagnosis, a large tumor was present in the right orbit, along with diffuse bone pain, pancyto-
penia and diffuse infiltration into bone marrow and into the CNS. Cytogenetic analysis of bone 
marrow cells showed chromosomal aberrations common to Rb, such as del(13q), i(6p), +1, and 
monosomy 16, besides others not yet described, including dup(5q), dic(15;22) and add(14q).
CASE REPORT
A 19-month-old girl was admitted to our institution with leukocoria in the left eye in 
December 2003. Retina mapping showed a vascularized, white-mass tumor with points of cal-
cification, occupying more than half of the retina and making it difficult to see the optic nerve. 
There was vitreous hemorrhage associated with endophytic and exophytic growth. Cranial 
computed tomography and magnetic resonance imaging revealed a localized left eye tumor. A 
histopathological study revealed an Rb that had surrounded the head of the optic nerve, but not 
beyond the lamina cribosa (Group V, Reese-Ellsworth classification) (Linn, 2005). Laboratory 
tests, cerebrospinal fluid (CSF) and bone marrow showed no abnormalities.
The patient was treated with enucleation and chemotherapy in accordance with a Bra-
zilian Retinoblastoma Protocol (Antonelli et al., 2003). The treatment was completed in May 
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2004, and she was followed up monthly. Four months after the end of the treatment, she was 
hospitalized with leg pain, lethargy, irritability, and a hardened tumor in the orbit of the right 
eye. A complete blood count revealed a low platelet count (49,000/mm³), and biochemical tests 
showed high levels of LDH (1033 IU). Cerebral tomography showed an extensive extra axial 
mass surrounding the frontal region. Anatomopathological examination of the tumor in the right 
orbit revealed the presence of malignant small-cell neoplasia and immunohistochemical tests 
were positive for S100 protein, synaptophysin, NSF, and GFAP, and negative for CD99 and 
NB84. Bone marrow showed a massive malignant infiltration of small round cells, with scarce 
and basophilic cytoplasm and few visible nucleoli. Immunophenotypic tests of tumors cells were 
negative for leukemia markers. Cytogenetic analysis by the G-banding disclosed the following: 
47,XX,+1,dup(5)(q11.2;q35),+i(6p),del(13)(q12;q14),add(14)(q32),dic(15;22)(p11.1;q13),
-16,+mar[10]/47,XX,+1,dup(5)(q11.2;q35),+i(6p),del(13)(q12;q14),add(14)(q32),dic(15;22)
(p11.1;q13)[5]/48,XX,+1,dup(5)(q11.2;q35),+i(6p),del(13)(q12;q14),add(14)(q32),dic(15;22)
(p11.1;q13),+mar[1] (Figure 1A). Fluorescent in situ hybridization (FISH) using a 6p probe 
(QBiogene) showed three signals: two normal 6p and one i(6p) in the five metaphases analyzed 
(Figure 1B). SKY analysis confirmed the abnormalities previously seen by G-banding and identi-
fied the origin of the marker chromosome as chromosome 1 (Figure 1C). The definitive karyotype 
found was 48,XX,+1,+1dup(5)(q11.2;q35),+i(6p),del(13)(q12;q14),add(14)(q32),dic(15;22)
(p11.1;q13),-16. RT-PCR analysis did not detect t(4,11), t(1,19), t(9,22), t(12,21), t(11;22) or 
amplifications of the MYCN gene in tumor cells or bone marrow.
Figure 1. G-banding, FISH and SKY analysis of the patient. A. G-banded karyotype: 47,XX,+1,dup(5)(q11.2;q35),+i(6)
(p10),del(13)(q12;q14),add(14)(q32),dic(15;22)(p11.1;q13),-16,+mar[10]. B. FISH using 6p probe. Arrow indicates 
i(6p). C. SKY karyotype showing the inverted DAPI (left) and the classified (right) profiles for each chromosome. 
Extra copies of chromosome 1, where one of them has insertion of part of chromosome 3, ins(1;3)(q21;q26q29),dup(5)
(q11.2;q35),+i(6)(p10),del(13)(q12;q14),t(14;16)(q32;q11.1),dic(15;22)(p11.1;q13, were indicated by arrows.
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The child was treated for relapse with ifosfamide, carboplatin and etoposide. In Feb-
ruary 2005, the child presented seizures and malignant cells infiltrating the spinal fluid. A new 
treatment was tried with carboplatin, vincristine and intrathecal chemotherapy, followed by 
cranial and neuraxial radiotherapy. In May 2005, the patient no longer responded to chemo-
therapy and died of progressive disease.
DISCUSSION
Since 1993, 125 Rb cases have been registered in our institution, but only one with 
bone marrow totally infiltrated by immature cells. Three similar cases have already been de-
scribed in the literature and the diagnoses were based on histopathological and cytogenetic 
studies (Inoue et al., 1974; Daly et al., 1987; Khurshid et al., 2004). The main cytogenetic 
alterations described in Rb are del(13), gain 1q and 6p, loss of 5q, and monosomy 16. Because 
few cases of Rb diffusely infiltrating in the bone marrow had been described, it is very difficult 
to know which cytogenetic alterations are involved and its relation to aggressiveness of disease.
The deletion of 13q is the alteration directly responsible for Rb, where the tumor sup-
pressor gene RB1 is located, also i(6p) is important since it is the most common abnormality 
found in 50 to 60% of Rb cases. The presence of i(6p) may be an important genetic change in 
the development and progression of the tumor (Paderova et al., 2007). Other regions such as 
1q36 (E2F2 and ID3), 2p24-25 (ID2 and MYCN), 9p (p16), and 16p22 (E2F4) are also involved 
in the pRb pathway. Perhaps these regions contribute towards a third event that is necessary 
for completing the malignant transformation (Mairal et al., 2000; Chen et al., 2001). The new 
cytogenetic abnormalities described in this case were duplication 5q, add(14q) and dic(15;22). 
It is possible that these changes played a role in the dissemination and progression of disease.
The atypical bilateral Rb case described here had an aggressive evolution with short 
period between diagnosis and relapse. The tumor cells did not respond to chemotherapy and 
the child died shortly afterwards. Certainly, the cytogenetic studies helped to diagnose the 
disease, but other cases of disseminated Rb need to be studied to clarify when cytogenetic 
abnormalities are present and to know whether they are present at the beginning of the disease, 
as well as determining their importance in the evolution of the disease.
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